Company Search:
Advanced Search
Sponsored Links
Carrus Capital Corp Company Snapshot
Carrus Capital Corp operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Carrus Capital Corp with three other pharmaceutical manufacturers in North America: InMed Pharmaceuticals Inc (2009 sales of 196,000.00 Canadian Dollars [US$159,479.32 ] ), Vericel Corp of the United States ($182,000.00 of which 100% was Autologous Cell Products), and Aptose Biosciences Inc (184,000.00 Canadian Dollars [US$149,715.28 ] of which 100% was Pharmaceuticals).

Sales Analysis.
  Stock Performance Chart for Carrus Capital Corp
  Stock Data: Recent Stock Performance:
  Current Price (9/15/2017): .98
(Figures in Canadian Dollars)
1 Week 8.9%   13 Weeks 125.3%  
4 Weeks 263.0%   52 Weeks 2,700.0%  
Carrus Capital Corp Key Data:
  Ticker: CHQ Country: Canada
  Exchanges: VEN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2009 Sales 198,000
(Year Ending Jan 2010).
Employees: 6
  Currency: Canadian Dollars Market Cap: 4,631,394
  Fiscal Yr Ends: April Shares Outstanding: 4,725,912
  Share Type: Common Closely Held Shares: 714,286
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.